Comparative study of silica nanoparticles and surface modified silica nanoparticles: Drug adsorption process and controlled release behavior

被引：4
作者：
Zhang, Ping [1 ]
Jiang, Qiankun [1 ]
Li, Jing [1 ]
机构：
[1] Shenyang Med Coll, Sch Pharm, Shenyang, Liaoning, Peoples R China
来源：
MATERIALS SCIENCE AND ENGINEERING B-ADVANCED FUNCTIONAL SOLID-STATE MATERIALS | 2020年 / 259卷
关键词：
Nanoscale silica; Surface modification; Drug adsorption; Controlled release; CARRIER; FUNCTIONALIZATION; MICROSPHERES; INCLUSION; XEROGELS; SBA-15;
D O I：
10.1016/j.mseb.2020.114609
中图分类号：
T [工业技术];
学科分类号：
08 ;
摘要：
The purpose of this study was to compare drug adsorption process and release behavior of commercial silica nanoparticles (Silica-01) and surface modified silica nanoparticles (Silica-03). Characteristics of Silica-01 and Silica-03, including specific surface area, pore size and morphology were given initially. Characteristics of diltiazem hydrochloride (DZH) loaded Silica-01 and indomethacin (IMC) loaded Silica-03 were described by differential scanning calorimeter (DSC), fourier transform infrared spectroscopy (FT-IR) and in vitro dissolution. It can be observed from scanning electron microscope (SEM) that Silica-03 was coated and possessed better dispersibility. Drug adsorption process revealed the competition between drug and solvent, and main influencing factors are polarity of solvent. FTIR indicated that DZH was adsorbed onto Silica-01 and IMC was adsorbed onto Silica-03 with hydrogen bond. Silica-01 and Silica-03 controlled drug release with a burst release and a sustained release, and Silica-03 could slow down burst release due to steric hinder caused by surface modification.
引用
收藏
页数：8
相关论文
共 21 条
[1]   Silica xerogel carrier material for controlled release of toremifene citrate [J].
Ahola, M ;
Kortesuo, P ;
Kangasniemi, I ;
Kiesvaara, J ;
Yli-Urpo, A .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 195 (1-2) :219-227
[2]   In vitro release of heparin from silica xerogels [J].
Ahola, MS ;
Säilynoja, ES ;
Raitavuo, MH ;
Vaahtio, MM ;
Salonen, JI ;
Yli-Urpo, AUO .
BIOMATERIALS, 2001, 22 (15) :2163-2170
[3]   Combined alkyl and sulfonic acid functionalization of MCM-41-type silica -: Part 1.: Synthesis and characterization [J].
Díaz, I ;
Márquez-Alvarez, C ;
Mohino, F ;
Pérez-Pariente, J ;
Sastre, E .
JOURNAL OF CATALYSIS, 2000, 193 (02) :283-294
[4]   The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses [J].
He, Qianjun ;
Zhang, Jiamin ;
Shi, Jianlin ;
Zhu, Ziyan ;
Zhang, Linxia ;
Bu, Wenbo ;
Guo, Limin ;
chen, Yu .
BIOMATERIALS, 2010, 31 (06) :1085-1092
[5]   3D cubic mesoporous silica microsphere as a carrier for poorly soluble drug carvedilol [J].
Hu, Yanchen ;
Zhi, Zhuangzhi ;
Zhao, Qinfu ;
Wu, Chao ;
Zhao, Peng ;
Jiang, Haitao ;
Jiang, Tongying ;
Wang, Siling .
MICROPOROUS AND MESOPOROUS MATERIALS, 2012, 147 (01) :94-101
[6]   Facile synthesis of 3D cubic mesoporous silica microspheres with a controllable pore size and their application for improved delivery of a water-insoluble drug [J].
Hu, Yanchen ;
Wang, Jing ;
Zhi, Zhuangzhi ;
Jiang, Tongying ;
Wang, Siling .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2011, 363 (01) :410-417
[7]   In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery [J].
Kortesuo, P ;
Ahola, M ;
Kangas, M ;
Kangasniemi, I ;
Yli-Urpo, A ;
Kiesvaara, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 200 (02) :223-229
[8]   Biomimetic synthesis of silica with chitosan-mediated morphology [J].
Leng, Boxun ;
Chen, Xin ;
Shao, Zhengzhong ;
Ming, Weihua .
SMALL, 2008, 4 (06) :755-758
[9]   Surface-modification in situ of nano-SiO2 and its structure and tribological properties [J].
Li, Xiaohong ;
Cao, Zhi ;
Zhang, Zhijun ;
Dang, Hongxin .
APPLIED SURFACE SCIENCE, 2006, 252 (22) :7856-7861
[10]   Novel hybrid silica xerogels for stabilization and controlled release of drug [J].
Maver, Uros ;
Godec, Aljaz ;
Bele, Marjan ;
Planinsek, Odon ;
Gaberscek, Miran ;
Srcic, Stane ;
Jamnik, Janko .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 330 (1-2) :164-174
123